Technical Analysis for SYN - Synthetic Biologics, Inc.

Grade Last Price % Change Price Change
grade D 0.7784 1.22% 0.01
SYN closed up 1.22 percent on Tuesday, March 19, 2019, on 77 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical SYN trend table...

Date Alert Name Type % Chg
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Above Upper BB Strength 0.00%
Mar 18 New Uptrend Bullish 1.22%
Mar 18 180 Bullish Setup Bullish Swing Setup 1.22%
Mar 18 Upper Bollinger Band Walk Strength 1.22%
Mar 18 Inside Day Range Contraction 1.22%
Mar 18 Above Upper BB Strength 1.22%
Mar 18 Upper Bollinger Band Touch Strength 1.22%
Mar 15 Volume Surge Other 9.63%

Older signals for SYN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases. The company's product candidates include Trimesta, which is in Phase II clinical trial for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis; SYN-004, which is in Phase II clinical trial for the treatment of clostridium difficile infection prevention; SYN-005, which is in preclinical stage for the treatment of pertussis; and SYN-001, which is in discovery stage for the treatment of acinetobacter infection. It has an agreement with Meda AB for the development and commercialization of Effirma (flupirtine) for fibromyalgia in the United States, Canada, and Japan, as well as with The University of Texas at Austin, Intrexon Corporation, and the Regents of the University of California. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetics Biologics, Inc. in February 2012. Synthetics Biologics, Inc. was founded in 2001 and is based in Rockville, Maryland.
Biotechnology Chemical Compounds Infectious Diseases Multiple Sclerosis Pyridines Carbamates Clostridioides Difficile Clostridium Difficile Infection Fibromyalgia Microorganisms University Of California Cognitive Dysfunction Flupirtine Relapsing Remitting Multiple Sclerosis
Is SYN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 502.25
52 Week Low 0.51
Average Volume 374,624
200-Day Moving Average 62.7619
50-Day Moving Average 0.6594
20-Day Moving Average 0.6819
10-Day Moving Average 0.7122
Average True Range 0.0583
ADX 27.89
+DI 32.2166
-DI 8.2581
Chandelier Exit (Long, 3 ATRs ) 0.675
Chandelier Exit (Short, 3 ATRs ) 0.7849
Upper Bollinger Band 0.779
Lower Bollinger Band 0.5848
Percent B (%b) 1.0
BandWidth 28.479249
MACD Line 0.0265
MACD Signal Line 0.0131
MACD Histogram 0.0134
Fundamentals Value
Market Cap 99.83 Million
Num Shares 128 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -4.75
Price-to-Sales 0.00
Price-to-Book 21.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.87
Resistance 3 (R3) 0.86 0.82 0.85
Resistance 2 (R2) 0.82 0.80 0.82 0.85
Resistance 1 (R1) 0.80 0.78 0.81 0.81 0.84
Pivot Point 0.76 0.76 0.76 0.76 0.76
Support 1 (S1) 0.74 0.74 0.75 0.75 0.72
Support 2 (S2) 0.70 0.72 0.71 0.71
Support 3 (S3) 0.68 0.70 0.71
Support 4 (S4) 0.69